Tissue injuries, with or without involvement of nerves, may lead to ongoing
pain and hyperalgesia to external stimuli. In a subset of patients, the pa
in is maintained by sympathetic efferent activity (SMP). We investigated if
the peripheral administration of the alpha -adrenergic agonist, norepineph
rine (NE), in physiologically relevant doses resulted in pain in patients w
ith SMP. To establish the dose of intradermal NE required to induce cutaneo
us vasoconstriction, NE (1 nM-10 muM, 30 mul) was injected under a laser Do
ppler probe on the volar forearm of seven normal subjects. A decrease in bl
ood how was evident at a dose of 10 muM Twelve patients (five male, seven f
emale) diagnosed to have SMP based on the decrease in pain by a local anest
hetic sympathetic blockade (70 +/- 6%) were enrolled in the study. Pain rat
ings were obtained continuously for 5 min after intradermal injections of s
aline and NE (0.1-10 muM) into their hyperalgesic zone and the mirror-image
contralateral side. Injections were done during the period of pain relief
following a local anesthetic sympathetic blockade. Similar injections were
made in eight control subjects. On the affected side of the patients, the t
wo highest concentrations of NE (1 and 10 muM) caused significantly more pa
in than saline (P < 0.05, ANOVA). In contrast, there was no significant pai
n induced by the NE injections in the unaffected side and in control subjec
ts. Six of nine patients tested reported a marked decrease in pain and hype
ralgesia following infusion of phentolamine (1 mg/kg over 10 min). Two of t
he three patients who did not receive pain relief following phentolamine in
fusion also did not report pain to the NE injections. We conclude that NE i
njections produce pain in SMP patients at doses that are at the threshold f
or producing vasoconstriction. These studies support a role for cutaneous a
drenoceptors in the mechanisms of sympathetically maintained pain. (C) 2000
international Association for the Study of Pain. Published by Elsevier Sci
ence B.V. All rights reserved.